Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

NCT03912402 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer
Cervical Cancer Metastatic
Cervical Cancer Recurrent

Interventions

BIOLOGICAL: BCD-100
BIOLOGICAL: Bevacizumab
DRUG: Paclitaxel
DRUG: Cisplatin (or carboplatin)

Sponsor

Biocad